The rare neurological disorder Angelman syndrome leads to a range of developmental and movement problems in...
Health
[wpseo_breadcrumb]
Healing Through Heritage: Why Culturally Grounded Recovery Matters on Tribal Lands
Across Tribal Nations, our communities are confronting a behavioral health crisis rooted in generations of...
How healthcare payment plans improve the patient experience
At A GlancePatient payment plans let patients spread healthcare costs over time instead of paying a full...
This Device Could Prevent Lung Biopsy’s Most Common — and Costly — Complication
Someone in the U.S. is diagnosed with lung cancer every two minutes, and for many of these people, the next...
The Pandemic Risk of “What I’ve Never Seen Before” – The Health Care Blog
By MIKE MAGEE The world of medical science largely closed ranks last month in defense of Tony Fauci. Dr. Fauci...
This Merger Wants to Prevent Rare Disease Patients from Losing Their Data
Two Irish health tech startups are joining forces to give patients one continuous health and research record...
Breaking the Amendment Cycle: How Agentic AI Enables Smarter Clinical Trial Design and Operations
Across the industry, we’ve normalized a “complexity tax” in clinical development, treating friction as if it’s...
“We’re Sorry, That’s the Policy”: How a Medicare Advantage Runaround Nearly Cost a Senior His Sight – The Health Care Blog
By FRANK LEAHY On a gray February morning, I sat in my office in Inverness, in rural northern California, with...
First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder
Polycythemia vera, a rare blood disease that that leads to a range of cardiovascular problems, has a new...
Claims management process strategies for claims acceptance success
At A GlanceThe claims management process determines how quickly and accurately a provider can move from patient...
Hospitals Are All In on AI, but Testing and Oversight Haven’t Caught Up
Health systems are more committed than ever to AI deployment, with most hospitals across the country now using...
SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven
SK Biopharmaceuticals, a South Korea-based drugmaker that already sells an FDA-approved epilepsy medicine, is...
Recommended
Search
Social
